top of page
Abstract Linear Background
Publications 2022

Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease. Brain Pathol. 2022 Dec 29;e13142.

​

Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview. Neurosci Biobehav Rev. 2023 Jan;144:104969.

 

Inflammasome activation in traumatic brain injury and Alzheimer's disease.

Transl Res. 2022 Sep 5;S1931-5244(22)00201-8.

 

Intraocular inflammasome signalling in failed corneal transplants.

Eye (Lond). 2022 Sep 12.

​

The inflammasome pathway: A key player in ocular surface and anterior segment diseases. Am J Ophthalmol. 2022 Jul;239:74-83.

 

Role of Caspase-1 as a Biomarker of Ocular Surface Damage. Am J Ophthalmol. 2022 Jul;239:74-83.

 

Mechanism of Action of IC 100, a Humanized IgG4 Monoclonal Antibody Targeting Apoptosis-Associated Speck-Like Protein Containing a Caspase Recruitment Domain (ASC). Transl Res. 2022 Jul 3:S1931-5244(22)00150-5. doi: 10.1016/j.trsl.2022.06.016.

 

Cohort study on the differential expression of inflammatory and angiogenic factors in thrombi, cerebral and peripheral plasma following acute large vessel occlusion stroke. J Cereb Blood Flow Metab. 2022 Jun 8;:271678X221106956.

​

Serum Caspase-1 as an Independent Prognostic Factor in Traumatic Brain Injured Patients. Neurocrit Care. 2022 Apr;36(2):527-535.

​

Renal and Inflammatory Proteins as Biomarkers of Diabetic Kidney Disease and Lupus Nephritis.Oxid Med Cell Longev. 2022;2022:5631099.

​

Role of Caspase-1 as a Biomarker of Ocular Surface Damage. Am J Ophthalmol. 2022 Feb 11;239:74-83.

​

The Role of Non-canonical and Canonical Inflammasomes in Inflammaging. Front Mol Neurosci. 2022;15:774014.

 

bottom of page